Dataset Information

Serum Peptidome Profiles Immune Response of COVID-19 Vaccine Administration

ABSTRACT: The study shows the promise of MALDI-TOF MS-based serum peptidome analysis for the assessment of immune responses activated by COVID-19 vaccination, and discovered a panel of serum peptides biomarkers for COVID-19 vaccination and for NAbs generation. The method developed in this study can help not only in the development of new vaccines, but also in the postmarketing evaluation of developed vaccines.

ORGANISM(S): Homo Sapiens

SUBMITTER: Liang Qiao

PROVIDER: PXD036159 | iProX | Fri Aug 19 00:00:00 BST 2022

REPOSITORIES: iProX

ACCESS DATA

Publications

Serum peptidome profiles immune response of COVID-19 Vaccine administration.

Zhang Wenjia W Li Dandan D Xu Bin B Xu Lanlan L Lyu Qian Q Liu Xiangyi X Li Zhijie Z Zhang Jian J Sun Wei W Ma Qingwei Q Qiao Liang L Liao Pu P

Frontiers in immunology 20220824

<h4>Background</h4>Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant loss of life and property. In response to the serious pandemic, recently developed vaccines against SARS-CoV-2 have been administrated to the public. Nevertheless, the research on human immunization response against COVID-19 vaccines is insufficient. Although much information associated with vaccine efficacy, safety and immunogenicity has been repor ...[more]

PMID: 36091008

Similar Datasets

Project description:In the last two years, the coronavirus disease 19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a scientific and social challenge worldwide. Vaccines have been the most effective intervention for reducing virus transmission and disease severity. However, virus genetic variants are still circulating among vaccinated individuals with different symptomatology disease cases. Understanding the protective or disease associated mechanisms in vaccinated individuals is relevant to advance in vaccine development and implementation. To address this objective, serum protein profiles were characterized by quantitative proteomics and data analysis algorithms in four cohorts of vaccinated individuals uninfected and SARS-CoV-2 infected with asymptomatic, nonsevere and severe disease symptomatology. The results showed that immunoglobulins were the most overrepresented proteins in infected cohorts when compared to PCR-negative individuals. The immunoglobulin profile varied between different infected cohorts and correlated with protective or disease associated capacity. Overrepresented immunoglobulins in PCR-positive individuals correlated with protective response against SARS-CoV-2, other viruses, and thrombosis in asymptomatic cases. In nonsevere cases, correlates of protection against SARS-CoV-2 and HBV together with risk of myasthenia gravis and allergy and autoantibodies were observed. Patients with severe symptoms presented risk for allergy, chronic idiopathic thrombocytopenic purpura, and autoantibodies. The analysis of underrepresented immunoglobulins in PCR-positive compared to PCR-negative individuals identified vaccine-induced protective epitopes in various coronavirus proteins including the Spike receptor-binding domain RBD. Non-immunoglobulin proteins were associated with COVID-19 symptoms and biological processes. These results evidence host-associated differences in response to vaccination and the possibility of improving vaccine efficacy against SARS-CoV-2.

Dataset Information

Serum Peptidome Profiles Immune Response of COVID-19 Vaccine Administration

Publications

Serum peptidome profiles immune response of COVID-19 Vaccine administration.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets